Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis

Adjuvant interferon (IFN) therapy following curative treatment for hepatocellular carcinoma (HCC) has been extensively investigated; however, the clinical benefits with different hepatitis backgrounds remain unclear. Medline, Embase, PubMed and the Cochrane Library databases were searched to identif...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular and clinical oncology 2014-11, Vol.2 (6), p.1125-1134
Hauptverfasser:	ZHANG, WEI, SONG, TIAN-QIANG, ZHANG, TI, WU, QIANG, KONG, DA-LU, LI, QIANG, SUN, HUI-CHUAN
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment China Comparative analysis Complications and side effects Health aspects Hepatitis Hepatitis B hepatitis C hepatocellular carcinoma Hepatoma Infections Interferon Liver cancer Liver cirrhosis Medical prognosis Meta-analysis Mortality Oncology Patients Risk factors Studies Surgery Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!